Drug-Induced Fever and Bone Marrow Suppression in a 12-Year-Old Girl with Cystic Fibrosis

Nathan D.G. Orkin SH . Hematology of Infancy and Childhood, 5th edn. Philadelphia: W B Saunders, 1998; 237–335

Oizumi K. Onuma K. Watanabe A. Motomiya M. Clinical study of drug fever induced by parenteral administration of antibiotics Tohoku J Exp Med 1989; 159: 45–56

Reichardt P. Handrick W. Linke A. Schille R. Kiess W. Leukocytopenia, thrombocytopenia and fever related to piperacillin/tazobactam treatment—a retrospective analysis in 38 children with cystic fibrosis. Infection 1999; 27: 355–6

Holt D.E. Ryder T.A. Fairbairn A. Hurley U. Harvey D. The myelotoxicity of chloramphenicol: in vitro and in vivo studies: I: In vitro effects on cells in culture. Hum Exp Toxicol 1997; 16: 570–6

Perez-Vaquez A. Pastor J.M. Riancho JA . Immune thrombocytopenia caused by piperacillin/tazobactam. Clin Infect Dis 1998; 27: 650–1

Gerber L. Wing EJ . Life threatening neutropenia secondary to piperacillin/tazobactam therapy. Clin Inject Dis 1995; 21: 1047–8

Young E.J. Fainstein V. Musher DM . Drug-induced fever: cases seen in the evaluation of unexplained fever in a general hospital population Rev Inject Dis 1982; 4: 69–77

Bystryn JC . Drug fever. Am J Med Sci 1972; 264: 473–4

Caldwell Cluff LE. Jr. Adverse reactions to antimicrobial agents JAMA 1974; 230: 77–80

Yow M.D. Taber L.H. Barrett F.F. A ten-year assessment of methicillin-associated side effects. Pediatrics 1976; 58: 329–334

Pleasants R.A. Walker T.R. Samuelson WM . Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis Chest 1994; 106: 1124–8

Lipsky B.A. Hirschmann JV . Drug fever. JAMA 1981; 245: 851–4

Singh N. Yu V.L. Micles L.A. Wagener MM . Beta-lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease Am J Med 1993; 94: 251–6